IRADIMED CORPORATION Available-for-sale Securities, Gross Unrealized Loss
IRADIMED CORPORATION (IRMD) reported Available-for-sale Securities, Gross Unrealized Loss of $82.19 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2018-03-08
- IRADIMED CORPORATION available-for-sale securities, gross unrealized loss for the quarter ending 2017-12-31 was $38.38K, a 9.70% decline year-over-year.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized loss for the quarter ending 2017-09-30 was -$5.65K.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized loss for the quarter ending 2017-06-30 was -$5.86K.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized loss for the quarter ending 2017-03-31 was $55.31K, a 27.08% decline year-over-year.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized loss for fiscal 2017 was $82.19K, a 30.36% increase from fiscal 2016.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized loss for fiscal 2016 was $63.05K, a 29.43% decline from fiscal 2015.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized loss for fiscal 2015 was $89.34K, a 157.51% increase from fiscal 2014.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized loss for fiscal 2014 was $34.69K.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 3 month | Available-for-sale Securities, Gross Unrealized Loss 6 month | Available-for-sale Securities, Gross Unrealized Loss 9 month | Available-for-sale Securities, Gross Unrealized Loss 12 month |
|---|---|---|---|---|
| 2017-12-31 | $38.38K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $32.73K derived: sum of 2 quarters · filed 2018-03-08 | $26.88K derived: sum of 3 quarters · filed 2018-03-08 | $82.19K 10-K · filed 2018-03-08 |
| 2017-09-30 | -$5.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$11.50K derived: sum of 2 quarters · filed 2017-11-06 | $43.81K 10-Q · filed 2017-11-06 | $86.31K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-06-30 | -$5.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $49.45K 10-Q · filed 2017-08-04 | $91.96K derived: sum of 3 quarters · filed 2018-03-08 | $68.57K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-03-31 | $55.31K 10-Q · filed 2017-05-05 | $97.81K derived: sum of 2 quarters · filed 2018-03-08 | $74.43K derived: sum of 3 quarters · filed 2018-03-08 | $42.51K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-12-31 | $42.50K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $19.12K derived: sum of 2 quarters · filed 2018-03-08 | -$12.80K derived: sum of 3 quarters · filed 2018-03-08 | $63.05K 10-K · filed 2018-03-08 |
| 2016-09-30 | -$23.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$55.30K derived: sum of 2 quarters · filed 2016-11-04 | $20.54K 10-Q · filed 2016-11-04 | $50.10K derived: sum of 4 quarters · filed 2017-03-10 |
| 2016-06-30 | -$31.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $43.93K 10-Q · filed 2016-08-05 | $73.49K derived: sum of 3 quarters · filed 2017-03-10 | $90.46K derived: sum of 4 quarters · filed 2017-03-10 |
| 2016-03-31 | $75.85K 10-Q · filed 2016-05-06 | $105.41K derived: sum of 2 quarters · filed 2017-03-10 | $122.38K derived: sum of 3 quarters · filed 2017-03-10 | $137.69K derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-12-31 | $29.56K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $46.53K derived: sum of 2 quarters · filed 2017-03-10 | $61.85K derived: sum of 3 quarters · filed 2017-03-10 | $89.34K 10-K · filed 2017-03-10 |
| 2015-09-30 | $16.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $32.28K derived: sum of 2 quarters · filed 2015-11-10 | $59.77K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $15.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $42.80K 10-Q · filed 2015-08-11 | ||
| 2015-03-31 | $27.49K 10-Q · filed 2015-05-11 | |||
| 2014-12-31 | $34.69K 10-K · filed 2016-03-10 | |||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | |||
| 2013-12-31 | $0.00 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |